QuilliChew ER (chewable methylphenidate)
QuilliChew ER is an advanced, central nervous system stimulant designed to provide consistent, all-day relief for ADHD symptoms in a convenient chewable tablet. It utilizes a specialized extended-release technology that delivers an initial dose of methylphenidate for immediate focus, followed by a gradual release to maintain attention and impulse control for up to 8 hours. Available in 20 mg, 30 mg, and 40 mg strengths, the tablets are functionally scored to allow for precise, individualized dose adjustments that can be tailored to a patient’s specific daily needs. As a Schedule II controlled substance, it requires proactive screening for heart conditions and regular 2026 clinical monitoring of blood pressure, heart rate, and pediatric growth to ensure long-term safety.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Introduction
QuilliChew ER is a central nervous system stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). QuilliChew ER is a chewable tablet taken by mouth.
It is not known if QuilliChew ER is safe and effective in children under 6 years of age.
What Are Side Effects of QuilliChew ER?
Common side effects of QuilliChew ER include:
- weight loss,
- anxiety,
- dizziness,
- irritability,
- mood swings,
- rapid heart rate,
- decreased appetite,
- aggression,
- headache,
- nausea,
- abdominal pain,
- indigestion,
- dry mouth,
- vomiting,
- insomnia,
- nervousness,
- restlessness,
- agitation,
- spinning sensation (vertigo),
- tremor,
- blurred vision,
- palpitations,
- increased sweating,
- fever, and
- increased blood pressure.
Seek medical care or call 911 at once if you have the following serious side effects:
- Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
- Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheadedness, or passing out;
- Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.
This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.
Dosage for QuilliChew ER
For patients 6 years and above, the recommended starting dose of QuilliChew ER is 20 mg given orally once daily in the morning.
What Drugs, Substances, or Supplements Interact with QuilliChew ER?
QuilliChew ER may interact with monoamine oxidase inhibitors (MAOIs). Tell your doctor all medications and supplements you or your child uses.
QuilliChew ER During Pregnancy and Breastfeeding
During pregnancy, QuilliChew ER should be used only if prescribed. It is unknown if it would affect a fetus. QuilliChew ER passes into breast milk. It is unknown if it would affect a nursing infant. Consult your doctor before breastfeeding. Withdrawal symptoms may occur if you suddenly stop taking QuilliChew ER.
Additional Information
Our QuilliChew ER (methylphenidate hydrochloride) extended-release chewable tablets Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.














Reviews
There are no reviews yet.